相关实验视频
Updated: May 29, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
肠道菌群的调节:一种新的免疫治疗方法,用于增强甲状腺癌治疗
Weiqiang Huang1, Tao Jiang2, Jiaxuan He2
1Department of General Surgery, The First People's Hospital of Jiashan, Jiashan Hospital Afliated of Jiaxing University, Jiaxing, 314100, China.
肠道微生物群通过免疫调节和炎症影响甲状腺癌 (TC) 的发展. 特定的肠道细菌及其代谢物可以作为早期的微生物标记物来检测甲状腺癌.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 对肠道微生物组在各种癌症中的作用越来越感兴趣.
- 新出现的证据表明,肠道菌群与甲状腺癌 (TC) 之间存在联系.
- 了解这种联系对于早期检测和新的治疗策略至关重要.
研究的目的:
- 审查肠道菌群和TC之间的关系.
- 为了识别与TC相关的特定肠道微生物.
- 探索微生物标记物用于TC预测.
主要方法:
- 文献综述侧重于肠道微生物群和甲状腺癌.
- 对研究免疫调节和TC病变发生中的炎症的研究进行分析.
- 检查肠道微生物代谢物 (SCFA,LPS) 在甲状腺功能中的作用.
主要成果:
- 特定的肠道菌群与甲状腺癌直接相关.
- 肠道微生物群影响免疫反应和与TC相关的慢性炎症.
- 微生物代谢物,如短链脂肪酸和脂多糖,影响甲状腺激素的合成和代谢.
结论:
- 肠道微生物组在甲状腺癌的发展中起着重要作用.
- 某些肠道细菌及其代谢物显示出作为TC预测生物标志物的潜力.
- 涉及益生菌,益生菌和营养补充剂的干预措施需要进一步调查TC管理.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Tumor Immunotherapy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

